bimekizumab,risankizumab
ucb biopharma,abbvie,boehringer ingelheim
['bimekizumab', 'risan', 'psoriasis', ' hs ']
chronic diseases like hs and #psoriasis are building stocks of viable therapies. here's what is looking forward to at #aad23 including new bimekizumab and risankizumab data: 
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.